The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, represents a complex multi-step organic process. Initial routes focused on peptide fragment coupling, utilizing solid-phase https://gerardemga285014.bloggin-ads.com/63842715/synthesis-and-investigation-applications-of-retatrutide